R Méndez

881 total citations
30 papers, 650 citations indexed

About

R Méndez is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, R Méndez has authored 30 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in R Méndez's work include Cardiac electrophysiology and arrhythmias (8 papers), Cardiac Arrhythmias and Treatments (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). R Méndez is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Cardiac Arrhythmias and Treatments (6 papers) and Atrial Fibrillation Management and Outcomes (3 papers). R Méndez collaborates with scholars based in Mexico, Brazil and United States. R Méndez's co-authors include Carlos F. Méndez, Gordon K. Moe, Gustavo Pastelı́n, Jorge Aceves, David Erlij, A. Farah, Manuel Martı́nez-López, José Jalife, J Cicciarelli and José Julio Laguna and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

R Méndez

30 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R Méndez Mexico 13 427 225 86 52 50 30 650
P Duchêne-Marullaz France 15 407 1.0× 285 1.3× 112 1.3× 17 0.3× 31 0.6× 109 676
Peter E. Dresel Canada 15 329 0.8× 189 0.8× 65 0.8× 24 0.5× 24 0.5× 67 624
E. Winslow United Kingdom 13 330 0.8× 345 1.5× 64 0.7× 22 0.4× 43 0.9× 43 611
Larry D. Davis United States 14 626 1.5× 399 1.8× 200 2.3× 33 0.6× 26 0.5× 37 964
G. Kuschinsky Germany 15 135 0.3× 275 1.2× 80 0.9× 21 0.4× 34 0.7× 99 751
Dennis S. Miura United States 16 569 1.3× 303 1.3× 109 1.3× 30 0.6× 35 0.7× 50 726
Peter Polster United Kingdom 10 267 0.6× 206 0.9× 102 1.2× 47 0.9× 13 0.3× 18 531
Martin M. Winbury United States 15 418 1.0× 164 0.7× 27 0.3× 47 0.9× 15 0.3× 47 846
Alan J. Higgins United Kingdom 12 259 0.6× 256 1.1× 69 0.8× 15 0.3× 21 0.4× 21 526
L. H. Smith United States 10 171 0.4× 213 0.9× 76 0.9× 13 0.3× 56 1.1× 29 637

Countries citing papers authored by R Méndez

Since Specialization
Citations

This map shows the geographic impact of R Méndez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R Méndez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R Méndez more than expected).

Fields of papers citing papers by R Méndez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R Méndez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R Méndez. The network helps show where R Méndez may publish in the future.

Co-authorship network of co-authors of R Méndez

This figure shows the co-authorship network connecting the top 25 collaborators of R Méndez. A scholar is included among the top collaborators of R Méndez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R Méndez. R Méndez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wada, Yoshimasa, Martin Walsh, John A. Montgomery, et al.. (1998). In Vitro Study of BCX-34: A New Human T-Lymphocyte–Specific Purine Phosphorylase Inhibitor. Transplantation Proceedings. 30(4). 983–986. 4 indexed citations
3.
Méndez, R. (1991). [200 years of digitalis].. PubMed. 33(3). 285–95. 3 indexed citations
4.
Muriana, Francisco J.G., R Méndez, & Angel M. Relimpio. (1991). Unusual regulatory properties of an halophilic aspartate aminotransferase.. The Journal of General and Applied Microbiology. 37(5). 395–402. 1 indexed citations
5.
Méndez, R. (1986). [200 years of digitalis].. PubMed. 56(4). 339–48. 2 indexed citations
6.
Pastelı́n, Gustavo & R Méndez. (1983). Cardiac effects of six actodigin (AY-22,241) - related semisynthetic glycosides. Life Sciences. 32(16). 1905–1909. 8 indexed citations
7.
Méndez, R. (1980). [Pharmacology of nitrites and adrenergic beta blockaders in coronary circulation].. PubMed. 50(3). 283–88. 1 indexed citations
8.
Pastelı́n, Gustavo, et al.. (1978). Disparity between the antihistaminic and antiarrhythmic activities of chlorpheniramine and its isomers. Life Sciences. 22(13-15). 1179–1188. 2 indexed citations
9.
Pastelı́n, Gustavo, R Méndez, & Gordon K. Moe. (1978). Participation of atrial specialized conduction pathways in atrial flutter.. Circulation Research. 42(3). 386–393. 33 indexed citations
10.
Pastelı́n, Gustavo, et al.. (1976). [Experimental anti-arrhythmic action of perhexiline].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 46(6). 696–706. 1 indexed citations
11.
Méndez, R, et al.. (1970). Cardiac Pharmacology. Annual Review of Pharmacology. 10(1). 291–312. 14 indexed citations
12.
Méndez, R, et al.. (1969). Antiarrhythmic actions of clemizole as pharmacologic evidence for a circus movement mechanism in atrial flutter. Naunyn-Schmiedeberg s Archives of Pharmacology. 262(3). 325–336. 9 indexed citations
13.
Martı́nez-López, Manuel, et al.. (1967). The action of the antihistaminic agents antazoline and meclizine on experimental arrhythmias.. PubMed. 22(2). 113–27. 8 indexed citations
14.
Méndez, R, et al.. (1966). BETA-RECEPTORS IN CORONARY VESSELS. The Lancet. 287(7443). 907–908. 7 indexed citations
15.
Erlij, David & R Méndez. (1964). THE MODIFICATION OF DIGITALIS INTOXICATION BY EXCLUDING ADRENERGIC INFLUENCES ON THE HEART. Journal of Pharmacology and Experimental Therapeutics. 144(1). 97–103. 86 indexed citations
16.
Méndez, Carlos F., Jorge Aceves, & R Méndez. (1961). THE ANTI-ADRENERGIC ACTION OF DIGITALIS ON THE REFRACTORY PERIOD OF THE A-V TRANSMISSION SYSTEM. Journal of Pharmacology and Experimental Therapeutics. 131(2). 199–204. 60 indexed citations
17.
Méndez, R, et al.. (1956). PHARMACOLOGIC ACTIONS OF ETHYL-METHYL-ISOOCTENYL AMINE (EMOA), A NEW PARASYMPATHETIC GANGLIONIC BLOCKING AGENT. Journal of Pharmacology and Experimental Therapeutics. 116(4). 377–386. 2 indexed citations
18.
Méndez, R & Carlos F. Méndez. (1953). THE ACTION OF CARDIAC GLYCOSIDES ON THE REFRACTORY PERIOD OF HEART TISSUES. Journal of Pharmacology and Experimental Therapeutics. 107(1). 24–36. 67 indexed citations
19.
Méndez, R, et al.. (1952). An experimental and clinical study on the effects of procaine amide (Pronestyl) on the heart. American Heart Journal. 43(6). 854–870. 32 indexed citations
20.
Moe, Gordon K. & R Méndez. (1951). The Action of Several Cardiac Glycosides on Conduction Velocity and Ventricular Excitability in the Dog Heart. Circulation. 4(5). 729–734. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026